Back to Search
Start Over
Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate RYANODEX for Exertional Heat Stroke
- Source :
- Plus Company Updates. August 31, 2018
- Publication Year :
- 2018
-
Abstract
- WOODCLIFF LAKE, N.J: Eagle Pharmaceuticals, Inc. has issued the following press release: Eagle Pharmaceuticals, Inc. ('Eagle' or 'the Company') (Nasdaq:EGRX) today announced completion of enrollment of the Company's second clinical [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.552530928